Opportunities and challenges with animal models for acute radiation syndrome drug discovery
Date
2018Journal
Expert Opinion on Drug DiscoveryPublisher
Taylor and Francis LtdType
Editorial
Metadata
Show full item recordSponsors
The authors gratefully acknowledge intramural research support from the Armed Forces Radiobiology Research Institute (RBB29173).Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054195521&doi=10.1080%2f17460441.2018.1526172&partnerID=40&md5=199279b8f93c9c041fdeb6cc81745985; http://hdl.handle.net/10713/8840ae974a485f413a2113503eed53cd6c53
10.1080/17460441.2018.1526172
Scopus Count
Collections
Related articles
- Animal models for acute radiation syndrome drug discovery.
- Authors: Singh VK, Newman VL, Berg AN, MacVittie TJ
- Issue date: 2015 May
- Nonhuman primates as models for the discovery and development of radiation countermeasures.
- Authors: Singh VK, Olabisi AO
- Issue date: 2017 Jul
- Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
- Authors: Singh VK, Kulkarni S, Fatanmi OO, Wise SY, Newman VL, Romaine PL, Hendrickson H, Gulani J, Ghosh SP, Kumar KS, Hauer-Jensen M
- Issue date: 2016 Mar
- Are animal models a necessity for acute radiation syndrome drug discovery?
- Authors: Schaue D, McBride WH
- Issue date: 2019 Jun
- Use of biomarkers for assessing radiation injury and efficacy of countermeasures.
- Authors: Singh VK, Newman VL, Romaine PL, Hauer-Jensen M, Pollard HB
- Issue date: 2016